The Filing Desk

Bioharvest Sciences vs United Guardian

Bioharvest Sciences BHST · United Guardian UG · Personal Care Products

Bioharvest Sciences reported revenue of $34 million in fiscal 2025, 3.3 times United Guardian's $10 million in fiscal 2025. Bioharvest Sciences' revenue grew 37.0% in its latest year, and United Guardian's fell 13.4%. Bioharvest Sciences had an operating margin of -16.2%, against 21.3% at United Guardian. Free cash flow was −$10 million at Bioharvest Sciences and $2 million at United Guardian.

Side by side

Bioharvest SciencesUnited Guardian
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$34M$10M
Revenue growth37.0%−13.4%
Revenue growth a year, last 5 years—−0.9%
Gross margin59.3%48.8%
Operating margin−16.2%21.3%
Net margin−32.3%20.0%
Free cash flow−$10M$2M
Free cash flow margin−27.8%18.1%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$3M
Change in diluted share count—0.0%
Last close$1.32$7.15
P/E at the last close——
Insider trades, last 12 months——
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Bioharvest SciencesUnited Guardian
Operating margin
Percent of revenue
Bioharvest SciencesUnited Guardian
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Bioharvest SciencesUnited Guardian

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Bioharvest Sciences and United Guardian pages.